D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 61 Citations 13,065 274 World Ranking 1943 National Ranking 50

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

Andrea De Luca mainly investigates Internal medicine, Immunology, Viral load, Genetics and Acquired immunodeficiency syndrome. Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Sida and Surgery. Her biological study spans a wide range of topics, including Cohort study and Ritonavir.

Her Immunology research incorporates themes from Nevirapine, Epidemiology and Incidence. Her research in Viral load intersects with topics in Chemotherapy, Viral disease, Regimen, Drug resistance and Drug. In general Genetics study, her work on Genome-wide association study, Allele and Gene often relates to the realm of Transmission, thereby connecting several areas of interest.

Her most cited work include:

  • A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 (1068 citations)
  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management (389 citations)
  • Common genetic variation and the control of HIV-1 in humans. (351 citations)

What are the main themes of her work throughout her whole career to date?

Her scientific interests lie mostly in Internal medicine, Immunology, Virology, Viral load and Regimen. Her work deals with themes such as Gastroenterology, Oncology and Ritonavir, which intersect with Internal medicine. Her Immunology research is multidisciplinary, incorporating elements of Acquired immunodeficiency syndrome, Incidence and Confidence interval.

Her studies in Virology integrate themes in fields like Protease inhibitor, Reverse transcriptase and Genotype. Andrea De Luca combines subjects such as Surgery, Drug resistance and Drug with her study of Viral load. As a member of one scientific family, Andrea De Luca mostly works in the field of Regimen, focusing on Lamivudine and, on occasion, Atazanavir.

She most often published in these fields:

  • Internal medicine (44.63%)
  • Immunology (36.48%)
  • Virology (30.94%)

What were the highlights of her more recent work (between 2015-2021)?

  • Internal medicine (44.63%)
  • Virology (30.94%)
  • Regimen (16.94%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Internal medicine, Virology, Regimen, Viral load and Lamivudine. Her Internal medicine study incorporates themes from Gastroenterology, Oncology and Ritonavir. Her research in Gastroenterology tackles topics such as Immunology which are related to areas like Pneumococcal conjugate vaccine and Group A.

Her biological study deals with issues like Raltegravir, which deal with fields such as Integrase inhibitor. Her study looks at the intersection of Regimen and topics like Dolutegravir with Tolerability and Public health. Andrea De Luca has included themes like Efficacy, Survival analysis and Drug resistance in her Viral load study.

Between 2015 and 2021, her most popular works were:

  • Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) (58 citations)
  • Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study (43 citations)
  • Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. (42 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

Her main research concerns Internal medicine, Ritonavir, Lamivudine, Regimen and Gastroenterology. Her Internal medicine research incorporates elements of Darunavir and Viral load. Viral load is the subject of her research, which falls under Immunology.

In her research on the topic of Immunology, Virology is strongly related with Hiv infected. Her study on Ritonavir also encompasses disciplines like

  • Randomized controlled trial which intersects with area such as Atazanavir Sulfate,
  • Ribavirin that intertwine with fields like Coinfection, Decompensation and Clinical trial. Her Regimen research includes themes of Switch therapy, Dolutegravir, Antiretroviral therapy and Drug.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo.
Science (2007)

1425 Citations

Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)

563 Citations

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn.
Lancet Infectious Diseases (2011)

455 Citations

Common genetic variation and the control of HIV-1 in humans.

Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo.
PLOS Genetics (2009)

442 Citations

Competing risks and prognostic stages of cirrhosis: A 25-year inception cohort study of 494 patients

G. D'Amico;L. Pasta;A. Morabito;M. D'Amico.
Alimentary Pharmacology & Therapeutics (2014)

396 Citations

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

Andrea De Luca;Roberto Bugarini;Alessandro Cozzi Lepri;Massimo Puoti.
JAMA Internal Medicine (2002)

314 Citations

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

Antonella Cingolani;Andrea Antinori;Maria Gabriella Rizzo;Rita Murri.
AIDS (2002)

312 Citations

Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.

Andrea Antinori;Antonella Cingolani;Lucia Alba;Adriana Ammassari.
AIDS (2001)

270 Citations

Patient-reported nonadherence to HAART is related to protease inhibitor levels.

Rita Murri;Adriana Ammassari;Keith Gallicano;Andrea De Luca.
Journal of Acquired Immune Deficiency Syndromes (2000)

204 Citations

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).

Andrea Antinori;Antonella Cingolani;Patrizia Lorenzini;Maria Letizia Giancola.
Journal of NeuroVirology (2003)

197 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Andrea De Luca

Jacques Fellay

Jacques Fellay

École Polytechnique Fédérale de Lausanne

Publications: 104

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 97

Carlo Federico Perno

Carlo Federico Perno

University of Milan

Publications: 97

Mary Carrington

Mary Carrington

MIT

Publications: 93

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 89

Andrea Antinori

Andrea Antinori

Catholic University of the Sacred Heart

Publications: 75

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 72

Cristina Mussini

Cristina Mussini

University of Modena and Reggio Emilia

Publications: 61

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 59

Philip J. R. Goulder

Philip J. R. Goulder

University of Oxford

Publications: 57

Adriano Lazzarin

Adriano Lazzarin

Vita-Salute San Raffaele University

Publications: 55

Dominique Costagliola

Dominique Costagliola

Sorbonne University

Publications: 54

Amalio Telenti

Amalio Telenti

Scripps Research Institute

Publications: 52

Antonella d'Arminio Monforte

Antonella d'Arminio Monforte

University of Milan

Publications: 50

Deenan Pillay

Deenan Pillay

University College London

Publications: 48

Enos Bernasconi

Enos Bernasconi

Universita della Svizzera Italiana

Publications: 48

Trending Scientists

Juan Nieto

Juan Nieto

Microsoft (United States)

Manoj Kumar

Manoj Kumar

Guru Nanak Dev University

Philip Gibbons

Philip Gibbons

Australian National University

Elmer H. Marth

Elmer H. Marth

University of Wisconsin–Madison

Christopher M. Overall

Christopher M. Overall

University of British Columbia

Niklas Höhne

Niklas Höhne

Wageningen University & Research

Leo Goeyens

Leo Goeyens

Vrije Universiteit Brussel

Seiji Kato

Seiji Kato

Langley Research Center

Joanne Berger-Sweeney

Joanne Berger-Sweeney

Tufts University

Michael W. Cole

Michael W. Cole

Rutgers, The State University of New Jersey

Shari L. Wade

Shari L. Wade

Cincinnati Children's Hospital Medical Center

Sanjay J. Mathew

Sanjay J. Mathew

Baylor College of Medicine

James E. Cutting

James E. Cutting

Cornell University

Paul Fockens

Paul Fockens

University of Amsterdam

Per Bech

Per Bech

University of Copenhagen

Juliet B. Schor

Juliet B. Schor

Boston College

Something went wrong. Please try again later.